Opinion
Video
Author(s):
Experts on bladder cancer discusses strategies to minimize adverse effects and the role of immunotherapy in BCG-unresponsive NMIBC treatment paradigms.
Nadofaragene firadenovec elicits high CR rate in phase 3 trial in Japan
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
Exploring new avenues in non–muscle invasive bladder cancer treatment
FDA approval sought for Anktiva in papillary NMIBC